Cargando…
Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.
The anti-tumour activity of CPT-11, a topoisomerase I inhibitor, was evaluated in four human neural-crest-derived paediatric tumour xenografts; one peripheral primitive neuroectodermal tumour (pPNET) (SK-N-MC) and three neuroblastomas. Two models, SK-N-MC and IGR-N835, were established in athymic mi...
Autores principales: | Vassal, G., Terrier-Lacombe, M. J., Bissery, M. C., Vénuat, A. M., Gyergyay, F., Bénard, J., Morizet, J., Boland, I., Ardouin, P., Bressac-de-Paillerets, B., Gouyette, A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074686/ https://www.ncbi.nlm.nih.gov/pubmed/8761367 |
Ejemplares similares
-
Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children
por: Avet-Loiseau, H, et al.
Publicado: (1999) -
Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations
por: Boland, I, et al.
Publicado: (1999) -
No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan
por: Calvet, L, et al.
Publicado: (2004) -
Primitive neuroectodermal tumor of the uterus
por: Elizalde, C.R., et al.
Publicado: (2016) -
Primitive neuroectodermal kidney tumour.
por: Khan, M. S., et al.
Publicado: (1995)